A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml. [electronic resource]
Producer: 20120315Description: 458-62 p. digitalISSN:- 0971-5916
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.